Josefine Krüger

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma

F. Bassermann, S. Müller, M. Wirth, 2022, Blood advances.

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma.

G. Willimsky, A. Nogai, A. Pezzutto, 2024, Haematologica.